169 related articles for article (PubMed ID: 31589317)
1. Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
Chkheidze R; Cimino PJ; Hatanpaa KJ; White CL; Ferreira M; Piccirillo SGM; Li L; Rajaram S; Nyagilo JO; Burns DK; Raisanen JM; Cai C
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1081-1088. PubMed ID: 31589317
[TBL] [Abstract][Full Text] [Related]
2. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
[TBL] [Abstract][Full Text] [Related]
3. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma.
Prayson RA; Chamberlain WA; Angelov L
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features.
Korhonen K; Parkkila AK; Helen P; Välimäki R; Pastorekova S; Pastorek J; Parkkila S; Haapasalo H
J Neurosurg; 2009 Sep; 111(3):472-7. PubMed ID: 19216648
[TBL] [Abstract][Full Text] [Related]
5. Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
Tauziede-Espariat A; Parfait B; Besnard A; Lacombe J; Pallud J; Tazi S; Puget S; Lot G; Terris B; Cohen J; Vidaud M; Figarella-Branger D; Monnien F; Polivka M; Adle-Biassette H; Varlet P
Brain Pathol; 2018 Jul; 28(4):466-474. PubMed ID: 28474749
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic iron deposition is associated with the expression of oxidative DNA damage marker in meningiomas.
Nagaishi M; Yokoo H; Osawa T; Nobusawa S; Tanaka Y; Ikota H; Yoshimoto Y; Nakazato Y
Neuropathology; 2013 Oct; 33(5):526-32. PubMed ID: 23406462
[TBL] [Abstract][Full Text] [Related]
7. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
Lin XY; Zhang H; Tang N; Zhang XP; Zhang W; Wang EH; Han YC
Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204
[TBL] [Abstract][Full Text] [Related]
8. SMARCE1 mutation screening in classification of clear cell meningiomas.
Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
[TBL] [Abstract][Full Text] [Related]
9. Angiomatous meningioma: a clinicopathologic study of 38 cases.
Hasselblatt M; Nolte KW; Paulus W
Am J Surg Pathol; 2004 Mar; 28(3):390-3. PubMed ID: 15104303
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
11. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.
Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S
Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344
[TBL] [Abstract][Full Text] [Related]
12. Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
Ahrendsen JT; Hsu N; Wolf Z; Bryke C; Varma H
J Neuropathol Exp Neurol; 2020 Jun; 79(6):618-625. PubMed ID: 32357369
[TBL] [Abstract][Full Text] [Related]
13. Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression.
Karimi S; Mansouri S; Mamatjan Y; Liu J; Nassiri F; Suppiah S; Singh O; Aldape K; Zadeh G
Sci Rep; 2020 Aug; 10(1):14115. PubMed ID: 32839486
[TBL] [Abstract][Full Text] [Related]
14. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
Jensen R; Lee J
Neurosurgery; 2012 Jul; 71(1):146-56. PubMed ID: 22472549
[TBL] [Abstract][Full Text] [Related]
15. Identification of shared genomic aberrations between angiomatous and microcystic meningiomas.
Kuroi Y; Akagawa H; Shibuya M; Onda H; Maegawa T; Kasuya H
Neurooncol Adv; 2019; 1(1):vdz028. PubMed ID: 32642661
[TBL] [Abstract][Full Text] [Related]
16. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
Yoo H; Baia GS; Smith JS; McDermott MW; Bollen AW; Vandenberg SR; Lamborn KR; Lal A
Clin Cancer Res; 2007 Jan; 13(1):68-75. PubMed ID: 17200340
[TBL] [Abstract][Full Text] [Related]
17. Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas.
Koizumi S; Sakai N; Kawaji H; Takehara Y; Yamashita S; Sakahara H; Baba S; Hiramatsu H; Sameshima T; Namba H
J Neurooncol; 2015 Feb; 121(3):549-56. PubMed ID: 25479828
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
[TBL] [Abstract][Full Text] [Related]
19. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
20. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
Sievers P; Sill M; Blume C; Tauziede-Espariat A; Schrimpf D; Stichel D; Reuss DE; Dogan H; Hartmann C; Mawrin C; Hasselblatt M; Stummer W; Schick U; Hench J; Frank S; Ketter R; Schweizer L; Schittenhelm J; Puget S; Brandner S; Jaunmuktane Z; Küsters B; Abdullaev Z; Pekmezci M; Snuderl M; Ratliff M; Herold-Mende C; Unterberg A; Aldape K; Ellison DW; Wesseling P; Reifenberger G; Wick W; Perry A; Varlet P; Pfister SM; Jones DTW; von Deimling A; Sahm F;
Acta Neuropathol; 2021 Feb; 141(2):281-290. PubMed ID: 33319313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
